Articles
Future oriented pharmaceutical processes – a key to success
An increase in requirements from regulatory agencies around the world, combined with a growing demand for drugs in prefilled injections systems – a trend...
News
PrecisionLife identifies 68 genes associated with high risk of severe COVID-19
Scientists from UK-headquartered AI precision medicine company, PrecisionLife, have found 68 genes associated with risk of developing severe COVID-19 by using its proprietary AI-enabled...
News
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals
La Jolla Pharmaceutical Company, which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases,...
Press Releases
Informa Pharma Intelligence Announces COVID-19 24-Hour Webinar Series
Informa Pharma Intelligence, announces an upcoming free 24-hour interactive webinar series entitled COVID-19 24-hour Web Event: Lessons Learned and a Path Forward. The event...
News
Avid Bioservices Names Nicholas Green as President and Chief Executive Officer
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing...
Press Releases
TraceLink Releases Results from FDA DSCSA Pilot Program on Top Pharmaceutical Supply Chain Challenges
TraceLink Inc. announced results from its pilot for the FDA Pilot Project Program under the Drug Supply Chain Security Act (DSCSA).
The TraceLink pilot focused...
Clinical Trials
Zealand Pharma announces first patient dosed in Phase 2 trial with long-acting GLP-1 dual agonist in obesity/diabetes
Zealand Pharma announced that the first patient has been dosed in a Phase 2 clinical trial of the long-acting GLP-1/glucagon dual agonist BI 456906,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read